Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma 2cm

This study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma 2 cm with

  • 0 views
  • 03 Jul, 2021
  • 6 locations
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma

Systematically mediastinal lymph node dissection or not in clinical stage T1 ground-glass dominated invasive lung adenocarcinoma: a multi-center, prospective clinical trial

  • 0 views
  • 06 May, 2022
  • 1 location
  • 0 views
  • 08 Apr, 2022
  • 1 location
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

This trial was to explore whether intravenous vitamin C can prolong resistance time of Tyrosine Kinase Inhibitor(TKI) on lung adenocarcinoma patients with Epidermal Growth Factor Receptor(EGFR

  • 0 views
  • 22 Jan, 2021
  • 1 location
Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation

This study is an open, prospective, single arm, multi center exploratory basket clinical study. 20 refractory solid tumors patients with rescuable p53 mutation will be enrolled, and the efficacy and safety of arsenic trioxide in those patients will be evaluated.

  • 0 views
  • 24 May, 2021
  • 1 location
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

there is a need for improving chemotherapy regimen for metastatic G3 NEC of GEP and Unknown origin and this goal may be achieved through more "personalized" chemotherapy regimen.the hypothesis is that mFOLFIRINOX regimen could be a good candidate for challenging the platinum-etoposide regimen in patients with metastatic G3 NEC of …

  • 4 views
  • 27 Apr, 2021
  • 6 locations
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC

with previously treated, advanced adenocarcinoma of the lung. The study will enroll three cohorts of participants with previously treated, advanced adenocarcinoma of the lung: Cohort A will consist of

cancer
alopecia
epidermal growth factor
adenocarcinoma
EGFR
  • 340 views
  • 29 Jan, 2022
  • 12 locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

gemcitabine
cancer
squamous cell carcinoma
adenocarcinoma
tumor cells
  • 1154 views
  • 08 Aug, 2022
  • 1029 locations
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

types likely to express NaPi2b were enrolled in dose escalation. Patients with platinum-resistant ovarian cancer and non-small cell lung cancer (adenocarcinoma subtype) are being enrolled in the

cancer
lung cancer
monoclonal antibodies
measurable disease
programmed cell death 1 ligand 1
  • 132 views
  • 19 Apr, 2022
  • 81 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

mucinous adenocarcinoma
gonadotrophin releasing hormone
squamous cell carcinoma
bilateral oophorectomy
carcinoma lung
  • 6634 views
  • 23 Jul, 2022
  • 753 locations